The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Resveratrol regulates microglia M1/M2 polarization via PGC-1α in conditions of neuroinflammatory injury
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“While the signaling pathway that involves M2b activation is largely unknown (Mantovani et al., 2004; Moehle and West, 2015; Mosser and Edwards, 2008).”
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“Thus far, the evidence presented for inflammation in neurodegenerative diseases points to an uncontrolled and prolonged M1-activated state that contributes to additional neuronal damage (Martinez and Gordon, 2014).”
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 2×
“Systemic injection of LPS has been reported to induce inflammatory responses and sickness behavior (Henry et al., 2008; Qin et al., 2007).”
Transcriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Hu, X., Li, P., Guo, Y., Wang, H., Leak, R. K., Chen, S., Gao, Y., & Chen, J. (2012) · Stroke · doi:10.1161/strokeaha.112.659656 · Cited by 1,535
Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Greaves, D. R., Murray, P. J., & Chawla, A. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.011 · Cited by 1,369 · cited 1×
“It has been reported that PGC-1β and PGC-1-related coactivator (PRC) both can regulate macrophage-mediated inflammation by interacting with STAT6 (Mou et al., 2015; Vats et al., 2006).”
The role of exercise and PGC1α in inflammation and chronic disease
Handschin, C., & Spiegelman, B. M. (2008) · Nature · doi:10.1038/nature07206 · Cited by 1,083
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884
Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Colton, C. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9164-4 · Cited by 877
SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T. J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802187200 · Cited by 778
Self-citationHenry, C. J., Huang, Y., Wynne, A., Hanke, M., Himler, J., Bailey, M. T., Sheridan, J. F., & Godbout, J. P. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-15 · Cited by 678
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 533
AMP-activated protein kinase and its downstream transcriptional pathways
Cantó, C., & Auwerx, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0454-z · Cited by 421
Resveratrol: Its Biologic Targets and Functional Activity
Pervaiz, S., & Holme, A. L. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2412 · Cited by 405
Microglia Priming with Aging and Stress
Niraula, A., Sheridan, J. F., & Godbout, J. P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.185 · Cited by 398
Handschin, C., Choi, C. S., Chin, S., Kim, S., Kawamori, D., Kurpad, A. J., Neubauer, N., Hu, J., Mootha, V. K., Kim, Y.-B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31785 · Cited by 335
Microglia-Mediated Inflammation and Neurodegenerative Disease
Xu, L., He, D., & Bai, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9593-4 · Cited by 332
The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis
Kieseier, B. C. (2011) · CNS Drugs · doi:10.2165/11591110-000000000-00000 · Cited by 308
Requirements for Interleukin-4-Induced Gene Expression and Functional Characterization of Stat6
Mikita, T., Campbell, D., Wu, P., Williamson, K., & Schindler, U. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5811 · Cited by 271
Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders
Jha, M. K., Lee, W.-H., & Suk, K. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.003 · Cited by 260
Role of Stat3 in Lipopolysaccharide-Induced IL-10 Gene Expression
Benkhart, E. M., Siedlar, M., Wedel, A., Werner, T., & Ziegler-Heitbrock, H. W. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1612 · Cited by 249
Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression
Pauleau, A.-L., Rutschman, R., Lang, R., Pernis, A., Watowich, S. S., & Murray, P. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7565 · Cited by 243
M1 and M2 immune activation in Parkinson’s Disease: Foe and ally?
Moehle, M. S., & West, A. B. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.018 · Cited by 200
STAT6‐dependent and ‐independent mechanisms in Th2 polarization
Maier, E., Duschl, A., & Horejs‐Hoeck, J. (2012) · European Journal of Immunology · doi:10.1002/eji.201242433 · Cited by 181
Lofrumento, D., Nicolardi, G., Cianciulli, A., Nuccio, F. D., Pesa, V. L., Carofiglio, V., Dragone, T., Calvello, R., & Panaro, M. (2014) · Innate Immunity · doi:10.1177/1753425913488429 · Cited by 153
Xu, Y., Xu, Y., Wang, Y., Wang, Y., He, L., Jiang, Z., Huang, Z., Liao, H., Li, J., Saavedra, J. M., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.07.015 · Cited by 150
Kim, H., Park, K., Yoo, E.-K., Kim, Y.-H., Kim, Y.-N., Kim, H., Kim, H. T., Park, J., Lee, K.-U., Jang, W. G., et al. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.1456 · Cited by 140
Burger, D., Molnarfi, N., Weber, M. S., Brandt, K. J., Benkhoucha, M., Gruaz, L., Chofflon, M., Zamvil, S. S., & Lalive, P. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812183106 · Cited by 135
Matsukawa, A., Takeda, K., Shinji, K. U. D. O., Maeda, T., Kagayama, M., & Akira, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6198 · Cited by 131
Nimmagadda, V. K. C., Bever, C. T., Vattikunta, N. R., Talat, S., Ahmad, V., Nagalla, N. K., Trisler, D. N., Judge, S. I. V., Royal, W., Chandrasekaran, K., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202584 · Cited by 131
The Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.11.012 · Cited by 131
IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells
Cianciulli, A., Dragone, T., Calvello, R., Porro, C., Trotta, T., Lofrumento, D. D., & Panaro, M. A. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2014.12.035 · Cited by 129
Tsunemi, T., & Spada, A. R. L. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.10.004 · Cited by 127
Tao, Y., Li, L., Jiang, B., Feng, Z., Yang, L., Tang, J., Chen, Q., Zhang, J., Tan, Q., Feng, H., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.020 · Cited by 121
Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK
Yang, Y., Hu, L., Xia, Y.-P., Jiang, C., Chen, M., Yang, C., Yuan, M., & Wang, L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0550-6 · Cited by 104
Plant-derived neuroprotective agents in Parkinson's disease.
Fu, W., Zhuang, W., Zhou, S., & Wang, X. (2015) · Europe PMC (PubMed Central) · Cited by 100
Camara, M. L., Corrigan, F., Jaehne, E. J., Jawahar, M. C., Anscomb, H., & Baune, B. T. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.199 · Cited by 98
Long-term follow-up of clinical trials of multiple sclerosis therapies
Freedman, M. S. (2010) · Neurology · doi:10.1212/wnl.0b013e318205051d · Cited by 85
Renaud, J., Bournival, J., Zottig, X., & Martinoli, M. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9439-7 · Cited by 77
NSAID use and risk of Parkinson disease: a population‐based case‐control study
Becker, C., Jick, S. S., & Meier, C. R. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03399.x · Cited by 76
Song, J., Cheon, S. Y., Jung, W., Lee, W. T., & Lee, J. E. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150915512 · Cited by 70
Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention?
Baune, B. T. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000140 · Cited by 57
Peroxisome proliferator‐activated receptor‐γ cofactors in neurodegeneration
Katsouri, L., Blondrath, K., & Sastre, M. (2012) · IUBMB Life · doi:10.1002/iub.1097 · Cited by 47
Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Porro, C., Cianciulli, A., Calvello, R., & Panaro, M. A. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150928155612 · Cited by 44
A Brief Overview of Multitalented Microglia
Joseph, B., & Venero, J. L. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-520-0_1 · Cited by 31
P4–029: Glutamate dysregulation in tau P301L mice
Hunsberger, H. C., Rudy, C. C., & Reed, M. N. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1417 · Cited by 29
PGC-1-Related Coactivator (PRC) Is an Important Regulator of Microglia M2 Polarization
Mou, C., Liu, B., Wang, M., Jiang, M., & Han, T. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0315-6 · Cited by 16
Cited by
Microglia polarization from M1 to M2 in neurodegenerative diseases
Guo, S., Wang, H., & Yin, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.815347 · Cited by 920
Liu, W., Rong, Y., Wang, J., Zhou, Z., Ge, X., Ji, C., Jiang, D., Gong, F., Li, L., Chen, J., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1726-7 · Cited by 573
Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8152373 · Cited by 403
Microglia Mediated Neuroinflammation in Parkinson’s Disease
Isik, S., Yeman Kiyak, B., Akbayir, R., Seyhali, R., & Arpaci, T. (2023) · Cells · doi:10.3390/cells12071012 · Cited by 379
Cai, Y., Liu, J., Wang, B., Sun, M., & Yang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856376 · Cited by 351
Metadata
- Authors
- Yang, X., Xu, S., Qian, Y., & Xiao, Q.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 64
- Pages
- 162-172
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W2594333208
- Cited by
- 413
- References
- 51
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.